For the Inventor, By the Inventor

Enter assignee name

Roussel Uclaf

USPTO Granted Patents = 854

CIPO Patents = 1

Trademarks = 6

Forward Citations = 6,662

Loading Chart...

Loading Chart...

474 inventors (with patents filed for the assignee):

Jean Tessier (100 out of 104 patents)

Jean-Pierre Demoute (89 out of 91 patents)

Jacques Martel (80 out of 82 patents)

4. Francois Clemence (71 out of 75 patents)

5. Lucien Nedelec (69 out of 72 patents)

6. Jean Buendia (51 out of 55 patents)

7. Odile Le Martret (47 out of 50 patents)

8. Daniel Philibert (46 out of 55 patents)

9. Roger Deraedt (39 out of 40 patents)

10. Michel Fortin (37 out of 43 patents)

11. Andre Teche (37 out of 37 patents)

12. Michel Vivat (35 out of 40 patents)

13. Fernando Barzaghi (34 out of 34 patents)

14. Claude Dumont (32 out of 32 patents)

15. Rene Heymes (31 out of 38 patents)

Core Competencies:

Cephalosporins

Erythromycins

Steroids

Imidazolidines

Phospholipids

Biological Control Agents

Nucleotide Sequences

Antiandrogenic Activity

Vasoconstriction Inhibition

Granule Preparation

Male Fertility Control

854 patents: Sort by Forward Citations

1. 5985292 - Active phospholipids as a vector for active molecules (1999-11-16),

2. 5965417 - Arabidepsi thaliana proteins having (1999-10-12),

3. 5917126 - Saccharose phosphate synthetase (SPS), a preparation method and CDNA (1999-06-29),

4. 5892028 - 17, 20-epoxy steroids (1999-04-06),

5. 5883248 - Cephalosporins (1999-03-16),

6. 5874076 - Administration of non-glycosylated, recombinant human IL.sub.2 in (1999-02-23),

7. 5869283 - Expression cassette operable in a recombinant host (1999-02-09),

8. 5856509 - Derivatives of imidazole, their preparation process, the new (1999-01-05),

9. 5847124 - Hydrated forms of zilpatherol hydrochloride (1998-12-08),

10. 5834452 - 1- or 6-hydroxylated steroids (1998-11-10),

11. 5830758 - Isolated V.beta. TCR antibodies (1998-11-03),

12. 5827887 - Biphenyl compounds (1998-10-27),

13. 5817674 - Quinoline compounds (1998-10-06),

14. 5817511 - Nucleotide sequence coding for variable regions of the .alpha. chains of (1998-10-06),

15. 5811445 - Method of preventing abnormal stimulation of AT.sub.1 and AT.sub.2 (1998-09-22),

Roussel Uclaf is a pharmaceutical company dedicated to improving and saving lives. With a focus on research and development, we strive to provide innovative solutions in various therapeutic areas. Our commitment to improving healthcare is evident through our high-quality products and dedication to meeting the needs of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

854 Patents

#15 in Paris

#30 in France

#1,165 in the World

Roussel Uclaf

Forward Citations = 6,662

474 inventors:

Jean Tessier (100 out of 104 patents)

Jean-Pierre Demoute (89 out of 91 patents)

Jacques Martel (80 out of 82 patents)

4. Francois Clemence (71 out of 75 patents)

5. Lucien Nedelec (69 out of 72 patents)

Please report any incorrect information to [email protected]

Loading…